Skip to main content
Erschienen in: European Journal of Nutrition 3/2016

19.05.2015 | Original Contribution

The effect of a cinnamon-, chromium- and magnesium-formulated honey on glycaemic control, weight loss and lipid parameters in type 2 diabetes: an open-label cross-over randomised controlled trial

verfasst von: Patricia Whitfield, Amber Parry-Strong, Emily Walsh, Mark Weatherall, Jeremy D. Krebs

Erschienen in: European Journal of Nutrition | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This randomised controlled trial assessed the acute and long-term effects of daily supplementation of kanuka honey, formulated with cinnamon, chromium and magnesium on glucose metabolism, weight and lipid parameters in individuals with type 2 diabetes.

Methods

Twelve individuals with type 2 diabetes received 53.5 g of a formulated honey and a control (non-formulated) kanuka honey in a random order for 40 days, using cross-over design. Fasting glucose, insulin, HbA1c, lipids and anthropometric measures were measured at baseline and end of treatment. A meal tolerance test was performed at baseline to assess acute metabolic response.

Results

There was no statistically significant difference in acute glucose metabolism between treatment groups, as measured by the Matsuda index and AUC for glucose and insulin. After the 40-day intervention with honey, fasting glucose did not differ significantly between the two treatments (95 % CI −2.6 to 0.07). There was no statistically significant change in HbA1c or fasting insulin. There was a statistically significant reduction in total cholesterol by −0.29 mmol/L (95 % CI −0.57 to −0.23), LDL cholesterol by −0.29 mmol/L (95 % CI −0.57 to −0.23) and weight by −2.2 kg (95 % CI −4.2 to −0.1). There was a trend towards increased HDL and reduced systolic blood pressure in the intervention treatment.

Conclusion

The addition of cinnamon, chromium and magnesium supplementation to kanuka honey was not associated with a significant improvement in glucose metabolism or glycaemic control in individuals with type 2 diabetes. Use of the formulated honey was associated with a reduction in weight and improvements in lipid parameters, and should be investigated further.
Literatur
2.
Zurück zum Zitat Agrawal OP, Pachauri A, Yadav H et al (2007) Subjects with impaired glucose tolerance exhibit a high degree of tolerance to honey. J Med Food 10:473–478CrossRef Agrawal OP, Pachauri A, Yadav H et al (2007) Subjects with impaired glucose tolerance exhibit a high degree of tolerance to honey. J Med Food 10:473–478CrossRef
3.
Zurück zum Zitat Al-Waili NS (2004) Natural honey lowers plasma glucose, C-reactive protein, homocysteine and blood lipids in healthy, diabetic and hyperlipidemic subjects: Comparison with dextrose and sucrose. J Med Food 7:100–107CrossRef Al-Waili NS (2004) Natural honey lowers plasma glucose, C-reactive protein, homocysteine and blood lipids in healthy, diabetic and hyperlipidemic subjects: Comparison with dextrose and sucrose. J Med Food 7:100–107CrossRef
4.
Zurück zum Zitat Erejuwa OO, Sulaiman SA, Ab Wahab MS (2012) Honey: a novel antidiabetic agent. Int J Biol Sci 8:913–934CrossRef Erejuwa OO, Sulaiman SA, Ab Wahab MS (2012) Honey: a novel antidiabetic agent. Int J Biol Sci 8:913–934CrossRef
5.
Zurück zum Zitat Erejuwa OO, Sulaiman SA, Ab Wahab MS et al (2001) Glibenclamide or metformin combined with honey improves glycemic control in streptozotocin-induced diabetic rats. Int J Biol Sci 7:244–252 Erejuwa OO, Sulaiman SA, Ab Wahab MS et al (2001) Glibenclamide or metformin combined with honey improves glycemic control in streptozotocin-induced diabetic rats. Int J Biol Sci 7:244–252
6.
Zurück zum Zitat Samanta A, Burden AC, Jones AR (1985) Plasma glucose responses to glucose, sucrose and honey in patients with diabetes mellitus: an analysis of glycaemic and peak incremental indices. Diabet Med 2:371–373CrossRef Samanta A, Burden AC, Jones AR (1985) Plasma glucose responses to glucose, sucrose and honey in patients with diabetes mellitus: an analysis of glycaemic and peak incremental indices. Diabet Med 2:371–373CrossRef
7.
Zurück zum Zitat Erejuwa OO, Sulaiman SA, Ab Wahab MS (2012) Oligosaccharides might contribute to the antidiabetic effect of honey: a review of the literature. Molecules 17:248–266CrossRef Erejuwa OO, Sulaiman SA, Ab Wahab MS (2012) Oligosaccharides might contribute to the antidiabetic effect of honey: a review of the literature. Molecules 17:248–266CrossRef
8.
Zurück zum Zitat Akilen R, Tsiami A, Devendra D, Robinson N (2012) Cinnamon in glycaemic control: systematic review and meta-analysis. Clin Nutr 31:609–615CrossRef Akilen R, Tsiami A, Devendra D, Robinson N (2012) Cinnamon in glycaemic control: systematic review and meta-analysis. Clin Nutr 31:609–615CrossRef
9.
Zurück zum Zitat Allen R, Schwartzman E, Baker W et al (2013) Cinnamon use in Type 2 diabetes: an updated systematic review and meta-analysis. Ann Fam Med 11:452–459CrossRef Allen R, Schwartzman E, Baker W et al (2013) Cinnamon use in Type 2 diabetes: an updated systematic review and meta-analysis. Ann Fam Med 11:452–459CrossRef
10.
Zurück zum Zitat Balk EM, Tatsioni A, Lichtenstein A et al (2007) Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials. Diabetes Care 30:2154–2163CrossRef Balk EM, Tatsioni A, Lichtenstein A et al (2007) Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials. Diabetes Care 30:2154–2163CrossRef
11.
Zurück zum Zitat Song Y, He K, Levitan B et al (2006) Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabet Med 23:1050–1056CrossRef Song Y, He K, Levitan B et al (2006) Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabet Med 23:1050–1056CrossRef
12.
Zurück zum Zitat Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470CrossRef Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470CrossRef
13.
Zurück zum Zitat Khan A, Safdar M, Khan MMA et al (2003) Cinnamon improves glucose and lipids of people with Type 2 diabetes. Diabetes Care 26:3215–3218CrossRef Khan A, Safdar M, Khan MMA et al (2003) Cinnamon improves glucose and lipids of people with Type 2 diabetes. Diabetes Care 26:3215–3218CrossRef
14.
Zurück zum Zitat Anderson RA, Cheng N, Bryden NA et al (1997) Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with Type 2 diabetes. Diabetes 46:1786–1791CrossRef Anderson RA, Cheng N, Bryden NA et al (1997) Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with Type 2 diabetes. Diabetes 46:1786–1791CrossRef
15.
Zurück zum Zitat Grant AP, McMullen JK (1982) The effect of brewer’s yeast containing glucose tolerance factor on the response to treatment in type 2 diabetics: a short controlled study. Ulster Med J 51:110–114 Grant AP, McMullen JK (1982) The effect of brewer’s yeast containing glucose tolerance factor on the response to treatment in type 2 diabetics: a short controlled study. Ulster Med J 51:110–114
16.
Zurück zum Zitat Bahijiri SM, Mira SA, Mufti AM, Ajabnoor MA (2000) The effects of inorganic chromium and brewer’s yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with Type 2 diabetes. Saudi Med J 21:831–837 Bahijiri SM, Mira SA, Mufti AM, Ajabnoor MA (2000) The effects of inorganic chromium and brewer’s yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with Type 2 diabetes. Saudi Med J 21:831–837
17.
Zurück zum Zitat Rabinowitz MB, Gonick HC, Levin SR, Davidson MB (1983) Effects of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic men. Diabetes Care 6:319–327CrossRef Rabinowitz MB, Gonick HC, Levin SR, Davidson MB (1983) Effects of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic men. Diabetes Care 6:319–327CrossRef
18.
Zurück zum Zitat Offenbacher EG, Pi-Sunyer FX (1980) Beneficial effects of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects. Diabetes 29:919–925CrossRef Offenbacher EG, Pi-Sunyer FX (1980) Beneficial effects of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects. Diabetes 29:919–925CrossRef
19.
Zurück zum Zitat Uusitupa MI, Kumpulainen JT, Voutilainen E et al (1983) Effect of inorganic chromium supplementation on glucose tolerance, insulin response and serum lipids in noninsulin-dependent diabetics. Am J Clin Nutr 38:404–410 Uusitupa MI, Kumpulainen JT, Voutilainen E et al (1983) Effect of inorganic chromium supplementation on glucose tolerance, insulin response and serum lipids in noninsulin-dependent diabetics. Am J Clin Nutr 38:404–410
20.
Zurück zum Zitat Sherman L, Glennon JA, Brech WJ et al (1968) Failure of trivalent chromium to improve hyperglycaemia in diabetes mellitus. Metabolism 17:439–442CrossRef Sherman L, Glennon JA, Brech WJ et al (1968) Failure of trivalent chromium to improve hyperglycaemia in diabetes mellitus. Metabolism 17:439–442CrossRef
21.
Zurück zum Zitat Magistrelli A, Chezem JC (2012) Effect of ground cinnamon on postprandial blood glucose concentration in normal-weight and obese adults. J Acad Nutr Diet 112:1806–1809CrossRef Magistrelli A, Chezem JC (2012) Effect of ground cinnamon on postprandial blood glucose concentration in normal-weight and obese adults. J Acad Nutr Diet 112:1806–1809CrossRef
22.
Zurück zum Zitat Erejuwa OO, Gurtu S, Sulaiman SA et al (2010) Hypoglycemic and antioxidant effects of honey supplementation in streptozotocin-induced diabetic rats. Int J Vitam Nutr Res 80:74–82CrossRef Erejuwa OO, Gurtu S, Sulaiman SA et al (2010) Hypoglycemic and antioxidant effects of honey supplementation in streptozotocin-induced diabetic rats. Int J Vitam Nutr Res 80:74–82CrossRef
23.
Zurück zum Zitat Chepulis L, Starkey N (2008) The long-term effects of feeding honey compared with sucrose and a sugar-free diet on weight gain, lipid profiles, and DEXA measurements in rats. J Food Sci 73:H1–H7CrossRef Chepulis L, Starkey N (2008) The long-term effects of feeding honey compared with sucrose and a sugar-free diet on weight gain, lipid profiles, and DEXA measurements in rats. J Food Sci 73:H1–H7CrossRef
24.
Zurück zum Zitat Nemoseck T, Carmody EG, Furchner-Evanson A et al (2011) Honey promotes lower weight gain, adiposity, and triglycerides than sucrose in rats. Nutr Res 31:55–60CrossRef Nemoseck T, Carmody EG, Furchner-Evanson A et al (2011) Honey promotes lower weight gain, adiposity, and triglycerides than sucrose in rats. Nutr Res 31:55–60CrossRef
25.
Zurück zum Zitat Bahrami M, Ataie-Jafari A, Hosseini S et al (2009) Effects of natural honey consumption in diabetic patients: an 8 week randomized clinical trial. Int J Food Sci Nutr 60:618–626CrossRef Bahrami M, Ataie-Jafari A, Hosseini S et al (2009) Effects of natural honey consumption in diabetic patients: an 8 week randomized clinical trial. Int J Food Sci Nutr 60:618–626CrossRef
26.
Zurück zum Zitat Abdulrhman M, El-Hefnawy MH, Aly RH et al (2013) Metabolic effects of honey in Type 1 diabetes mellitus: a randomized crossover pilot study. J Med Food 16:66–72CrossRef Abdulrhman M, El-Hefnawy MH, Aly RH et al (2013) Metabolic effects of honey in Type 1 diabetes mellitus: a randomized crossover pilot study. J Med Food 16:66–72CrossRef
27.
Zurück zum Zitat Yaghoobi N, Al-Waili N, Ghayour-Mobarhan M et al (2008) Natural honey and cardiovascular risk factors; effects on blood glucose, cholesterol, triacylglycerole, CRP, and body weight compared with sucrose. Sci World J 8:463–469CrossRef Yaghoobi N, Al-Waili N, Ghayour-Mobarhan M et al (2008) Natural honey and cardiovascular risk factors; effects on blood glucose, cholesterol, triacylglycerole, CRP, and body weight compared with sucrose. Sci World J 8:463–469CrossRef
28.
Zurück zum Zitat Deibert P, König D, Kloock B et al (2010) Glycaemic and insulinaemic properties of some German honey varieties. Eur J Clin Nutr 64:762–764CrossRef Deibert P, König D, Kloock B et al (2010) Glycaemic and insulinaemic properties of some German honey varieties. Eur J Clin Nutr 64:762–764CrossRef
29.
Zurück zum Zitat Cao H, Urban JF, Anderson RA (2007) Cinnamon extract and polyphenols affect the expression of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3T3-L1 adipocytes. Arch Biochem Biophys 459:214–222CrossRef Cao H, Urban JF, Anderson RA (2007) Cinnamon extract and polyphenols affect the expression of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3T3-L1 adipocytes. Arch Biochem Biophys 459:214–222CrossRef
30.
Zurück zum Zitat Jeejeebhoy KN, Chu RC, Marliss EB et al (1977) Chromium deficiency, glucose intolerance and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr 30:531–538 Jeejeebhoy KN, Chu RC, Marliss EB et al (1977) Chromium deficiency, glucose intolerance and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr 30:531–538
31.
Zurück zum Zitat Sundaram B, Singhal K, Sandhir R (2012) Ameliorating effect of chromium administration on hepatic glucose metabolism in streptozotocin-induced experimental diabetes. BioFactors 38:59–68CrossRef Sundaram B, Singhal K, Sandhir R (2012) Ameliorating effect of chromium administration on hepatic glucose metabolism in streptozotocin-induced experimental diabetes. BioFactors 38:59–68CrossRef
32.
Zurück zum Zitat Abdollahi M, Farshchi A, Nikfar S, Seyedifar M (2013) Effect of chromium on glucose and lipid profiles in patients with Type 2 diabetes; A meta-analysis review of randomized trials. J Pharm Pharm Sci 16:99–114 Abdollahi M, Farshchi A, Nikfar S, Seyedifar M (2013) Effect of chromium on glucose and lipid profiles in patients with Type 2 diabetes; A meta-analysis review of randomized trials. J Pharm Pharm Sci 16:99–114
33.
Zurück zum Zitat Suárez A, Pulido N, Casla A et al (1995) Impaired tyrosine–kinase activity of muscle insulin receptors from hypomagnesaemic rats. Diabetologia 38:1262–1270CrossRef Suárez A, Pulido N, Casla A et al (1995) Impaired tyrosine–kinase activity of muscle insulin receptors from hypomagnesaemic rats. Diabetologia 38:1262–1270CrossRef
34.
Zurück zum Zitat Rodríguez-Morán M, Guerrero-Romero F (2011) Insulin secretion is decreased in non-diabetic individuals with hypomagnesaemia. Diabetes Metab Res 27:590–596CrossRef Rodríguez-Morán M, Guerrero-Romero F (2011) Insulin secretion is decreased in non-diabetic individuals with hypomagnesaemia. Diabetes Metab Res 27:590–596CrossRef
35.
Zurück zum Zitat Baker W, Gutierrez-Williams G, White CM et al (2008) Effect of cinnamon on glucose control and lipid parameters. Diabetes Care 31:41–43CrossRef Baker W, Gutierrez-Williams G, White CM et al (2008) Effect of cinnamon on glucose control and lipid parameters. Diabetes Care 31:41–43CrossRef
36.
Zurück zum Zitat Letinsky D, Kelsberg G (2011) Is cinnamon safe and effective for treating lipid disorders? J Fam Pract 60:43–44 Letinsky D, Kelsberg G (2011) Is cinnamon safe and effective for treating lipid disorders? J Fam Pract 60:43–44
37.
Zurück zum Zitat Ranasinghe P, Jayawardana R, Galappaththy P et al (2012) Efficacy and safety of ‘true’ cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: a systematic review and meta-analysis. Diabet Med 29:1480–1492CrossRef Ranasinghe P, Jayawardana R, Galappaththy P et al (2012) Efficacy and safety of ‘true’ cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: a systematic review and meta-analysis. Diabet Med 29:1480–1492CrossRef
38.
Zurück zum Zitat Akilen R, Tsiami A, Devendra D, Robinson N (2010) Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-ethnic Type 2 diabetic patients in the UK: a randomized placebo-controlled, double-blind clinical trial. Diabet Med 27:1159–1167CrossRef Akilen R, Tsiami A, Devendra D, Robinson N (2010) Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-ethnic Type 2 diabetic patients in the UK: a randomized placebo-controlled, double-blind clinical trial. Diabet Med 27:1159–1167CrossRef
39.
Zurück zum Zitat Ziegenfuss TN, Hofheins JE, Mendel RW et al (2006) Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women. J Int Soc Sports Nutr 3:45–53CrossRef Ziegenfuss TN, Hofheins JE, Mendel RW et al (2006) Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women. J Int Soc Sports Nutr 3:45–53CrossRef
40.
Zurück zum Zitat Anton SD, Morrison CD, Cefalu WT et al (2008) Effects of chromium picolinate on food intake and satiety. Diabetes Technol Ther 10:405–412CrossRef Anton SD, Morrison CD, Cefalu WT et al (2008) Effects of chromium picolinate on food intake and satiety. Diabetes Technol Ther 10:405–412CrossRef
41.
Zurück zum Zitat Hlebowicz J, Darwiche G, Björgell O, Almér L-O (2007) Effect of cinnamon on postprandial blood glucose, gastric emptying, and satiety in healthy subjects. Am J Clin Nutr 85:1552–1556 Hlebowicz J, Darwiche G, Björgell O, Almér L-O (2007) Effect of cinnamon on postprandial blood glucose, gastric emptying, and satiety in healthy subjects. Am J Clin Nutr 85:1552–1556
42.
Zurück zum Zitat Akilen R, Pimlott Z, Tsiami A, Robinson N (2013) Effect of short-term administration of cinnamon on blood pressure in patients with prediabetes and Type 2 diabetes. Nutrition 29:1192–1196CrossRef Akilen R, Pimlott Z, Tsiami A, Robinson N (2013) Effect of short-term administration of cinnamon on blood pressure in patients with prediabetes and Type 2 diabetes. Nutrition 29:1192–1196CrossRef
Metadaten
Titel
The effect of a cinnamon-, chromium- and magnesium-formulated honey on glycaemic control, weight loss and lipid parameters in type 2 diabetes: an open-label cross-over randomised controlled trial
verfasst von
Patricia Whitfield
Amber Parry-Strong
Emily Walsh
Mark Weatherall
Jeremy D. Krebs
Publikationsdatum
19.05.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nutrition / Ausgabe 3/2016
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-015-0926-x

Weitere Artikel der Ausgabe 3/2016

European Journal of Nutrition 3/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.